Terms: = Cervical cancer AND TOP2A, TOP2, TP2A
36 results:
1. HPV16 E6 promoting cervical cancer progression through down-regulation of miR-320a to increase top2a expression.
Zhang J; Yu X; Guo Y; Wang D
Cancer Med; 2024 Feb; 13(3):e6875. PubMed ID: 38205938
[TBL] [Abstract] [Full Text] [Related]
2. [Expression of ProEXC and PRMT5 in cervical adenocarcinoma and their clinical significance].
Cui HX; Lou XL; Xia W; Zhang YS; Cheng XY; Deng LF
Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(48):3967-3971. PubMed ID: 38129175
[TBL] [Abstract] [Full Text] [Related]
3. Bioinformatics and cheminformatics approaches to identify pathways, molecular mechanisms and drug substances related to genetic basis of cervical cancer.
Andalib KMS; Rahman MH; Habib A
J Biomol Struct Dyn; 2023; 41(23):14232-14247. PubMed ID: 36852684
[TBL] [Abstract] [Full Text] [Related]
4. Sequential gene expression analysis of cervical malignant transformation identifies RFC4 as a novel diagnostic and prognostic biomarker.
Zhang J; Meng S; Wang X; Wang J; Fan X; Sun H; Ning R; Xiao B; Li X; Jia Y; Kong D; Chen R; Wang C; Ma D; Li S
BMC Med; 2022 Nov; 20(1):437. PubMed ID: 36352434
[TBL] [Abstract] [Full Text] [Related]
5. Role of APOA1 in the resistance to platinum-based chemotherapy in squamous cervical cancer.
He Y; Han SB; Liu Y; Zhang JJ; Wu YM
BMC Cancer; 2022 Apr; 22(1):411. PubMed ID: 35421932
[TBL] [Abstract] [Full Text] [Related]
6. Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for cervical cancer.
Reza MS; Harun-Or-Roshid M; Islam MA; Hossen MA; Hossain MT; Feng S; Xi W; Mollah MNH; Wei Y
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409328
[TBL] [Abstract] [Full Text] [Related]
7. Clinical Utility of Reflex Testing with cancer Biomarkers to Improve Diagnostic Accuracy of Primary Human Papillomavirus Screening.
Johnson LG; Saidu R; Svanholm-Barrie C; Boa R; Moodley J; Tergas A; Persing D; Campbell SA; Tsai WY; Wright TC; Denny L; Kuhn L
Cancer Epidemiol Biomarkers Prev; 2022 Mar; 31(3):595-603. PubMed ID: 35027434
[TBL] [Abstract] [Full Text] [Related]
8. Expression analysis of p16 and top2a protein biomarkers in cervical cancer lesions and their correlation with clinico-histopathological characteristics in a referral hospital, Tanzania.
Zuberi Z; Mremi A; Chilongola JO; Semango G; Sauli E
PLoS One; 2021; 16(10):e0259096. PubMed ID: 34705880
[TBL] [Abstract] [Full Text] [Related]
9.
Youssef FS; Labib RM; Gad HA; Eid S; Ashour ML; Eid HH
Food Funct; 2021 Jun; 12(12):5247-5259. PubMed ID: 33988201
[TBL] [Abstract] [Full Text] [Related]
10. top2a/MCM2, p16
Del Moral-Hernández O; Hernández-Sotelo D; Alarcón-Romero LDC; Mendoza-Catalán MA; Flores-Alfaro E; Castro-Coronel Y; Ortiz-Ortiz J; Leyva-Vázquez MA; Ortuño-Pineda C; Castro-Mora W; Illades-Aguiar B
BMC Cancer; 2021 Jan; 21(1):39. PubMed ID: 33413211
[TBL] [Abstract] [Full Text] [Related]
11. Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for cervical cancer: A Bioinformatics Analysis.
Qiu HZ; Huang J; Xiang CC; Li R; Zuo ED; Zhang Y; Shan L; Cheng X
Technol Cancer Res Treat; 2020; 19():1533033820980112. PubMed ID: 33302814
[TBL] [Abstract] [Full Text] [Related]
12. Human Papillomavirus E7 Oncoprotein Promotes Proliferation and Migration through the Transcription Factor E2F1 in cervical cancer Cells.
Tian S; Zhang L; Li Y; Cao D; Quan S; Guo Y; Yang X; Yang T
Anticancer Agents Med Chem; 2021; 21(13):1689-1696. PubMed ID: 33155930
[TBL] [Abstract] [Full Text] [Related]
13. top2a and CENPF are synergistic master regulators activated in cervical cancer.
Yu B; Chen L; Zhang W; Li Y; Zhang Y; Gao Y; Teng X; Zou L; Wang Q; Jia H; Liu X; Zheng H; Hou P; Yu H; Sun Y; Zhang Z; Zhang P; Zhang L
BMC Med Genomics; 2020 Oct; 13(1):145. PubMed ID: 33023625
[TBL] [Abstract] [Full Text] [Related]
14. Integrated analysis of key microRNAs /TFs /mRNAs/ in HPV-positive cervical cancer based on microRNA sequencing and bioinformatics analysis.
Yuan Y; Shi X; Li B; Peng M; Zhu T; Lv G; Liu L; Jin H; Li L; Qin D
Pathol Res Pract; 2020 Jun; 216(6):152952. PubMed ID: 32307200
[TBL] [Abstract] [Full Text] [Related]
15. Identification of key genes and pathways of diagnosis and prognosis in cervical cancer by bioinformatics analysis.
Yang HJ; Xue JM; Li J; Wan LH; Zhu YX
Mol Genet Genomic Med; 2020 Jun; 8(6):e1200. PubMed ID: 32181600
[TBL] [Abstract] [Full Text] [Related]
16. Comprehensive Analysis of Differential Gene Expression to Identify Common Gene Signatures in Multiple cancers.
Xue JM; Liu Y; Wan LH; Zhu YX
Med Sci Monit; 2020 Feb; 26():e919953. PubMed ID: 32035007
[TBL] [Abstract] [Full Text] [Related]
17. Identification of Key Genes and Pathways in cervical cancer by Bioinformatics Analysis.
Wu X; Peng L; Zhang Y; Chen S; Lei Q; Li G; Zhang C
Int J Med Sci; 2019; 16(6):800-812. PubMed ID: 31337953
[TBL] [Abstract] [Full Text] [Related]
18. Vosaroxin induces mitochondrial dysfunction and apoptosis in cervical cancer HeLa cells: Involvement of AMPK/Sirt3/HIF-1 pathway.
Zhao XL; Yu CZ
Chem Biol Interact; 2018 Jun; 290():57-63. PubMed ID: 29800573
[TBL] [Abstract] [Full Text] [Related]
19. Integrated analysis reveals down-regulation of SPARCL1 is correlated with cervical cancer development and progression.
Wu DM; Shi J; Liu T; Deng SH; Han R; Xu Y
Cancer Biomark; 2018 Feb; 21(2):355-365. PubMed ID: 29103025
[TBL] [Abstract] [Full Text] [Related]
20. Associations between epidermal growth factor receptor and topoisomerase II-alpha gene copy number variations, human papillomavirus positivity, and cytologic analysis in cervical cell lesions.
Kaya I; Sivrikoz ON; Etlik Ö; Gök A
Indian J Pathol Microbiol; 2017; 60(3):328-335. PubMed ID: 28937367
[TBL] [Abstract] [Full Text] [Related]
[Next]
